Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jie Zhao, Liangfeng Jiang, Haodong Yang, Lan Deng, Xiaoqing Meng, Jian Ding, Sixing Yang, Le Zhao, Wei Xu, Xiaolong Wang, Zhenping Zhu & Haomin Huang. (2022) A strategy for the efficient construction of anti-PD1-based bispecific antibodies with desired IgG-like properties. mAbs 14:1.
Read now
Read now
Dennis J. Underwood, Jeffrey Bettencourt & Zahra Jawad. (2022) The manufacturing considerations of bispecific antibodies. Expert Opinion on Biological Therapy 22:8, pages 1043-1065.
Read now
Read now
Danyang Gong, Timothy P. Riley, Krzysztof P. Bzymek, Ana R. Correia, Danqing Li, Christopher Spahr, John H. Robinson, Ryan B. Case, Zhulun Wang & Fernando Garces. (2021) Rational selection of building blocks for the assembly of bispecific antibodies. mAbs 13:1.
Read now
Read now
Kathryn H. Ching, Kimberley Berg, Kevin Reynolds, Darlene Pedersen, Alba Macias, Yasmina N. Abdiche, William D. Harriman & Philip A. Leighton. (2021) Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics. mAbs 13:1.
Read now
Read now
Zehua Sun, Chuan Chen, Wei Li, David R. Martinez, Aleksandra Drelich, Du-San Baek, Xianglei Liu, John W. Mellors, Chien-Te Tseng, Ralph S. Baric & Dimiter S. Dimitrov. (2020) Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold. mAbs 12:1.
Read now
Read now